<DOC>
	<DOCNO>NCT01427868</DOCNO>
	<brief_summary>The study compare pharmacokinetics LB80331 LB80317 , metabolites LB80380 , single oral administration LB80380 free base 150 mg ( 60 mg + 90 mg ) tablet LB80380 maleate tablet 183 mg ( 150 mg free base ) healthy male subject .</brief_summary>
	<brief_title>Bioequivalence LB80380 Free Base Maleate Salt Tablets</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Maleic acid</mesh_term>
	<criteria>Male good health 20 45 year age screen Body weight Â±20 % ideal body weight Willingness ability comply study procedure communicate investigator Provided write consent voluntarily inform pertinent aspects trial Clinically significant abnormality medical interview , physical examination , electrocardiogram clinical laboratory evaluation Clinically significant acute chronic medical condition Use prescriptive medicine within 14 day , overthecounter drug within 7 day first day drug administration Participation clinical trial within 3 month first day drug administration Alcohol abuse Habitual smoker Habitual user herbal medicine Use grapefruitcontaining food grapefruit juice study period Positive drug abuse test Positive HBsantigen , HCVantibody , HIVantibody test</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>LB80380</keyword>
	<keyword>bioequivalence</keyword>
</DOC>